La Crosse encephalitis, caused by the La Crosse virus (LACV), is a rare central nervous system (CNS) infection that is predominantly seen in the basins of the Mississippi and Ohio rivers, and the name was given after the first case was confirmed in La Crosse, Wisconsin [1] [2]. Humans are infected by this virus after being bitten by Aedes triseriatus, the local forest-dwelling mosquito, and a stable animal reservoir of the virus was identified to be among chipmunks and squirrels in these areas [1] [2]. For this reason, the infection is considered to be of zoonotic nature, and the summer months are when most cases are reported [3] [4] [5]. The majority of individuals who get infected by the LACV develop an asymptomatic form of illness and rough estimates suggest that approximately 1 in 1000 patients suffers from a more severe form of illness [1] [2]. La Crosse encephalitis is predominantly diagnosed in children under 15 years of age, and the incubation period symptoms appear about 3-7 days after being bitten by an infected mosquito [1] [8]. Seizures, altered mental state, cognitive impairment, and coma are main clinical features, whereas fever headaches, vomiting, and other neurological deficits (hemiparesis, dysarthria, chorea, and aphasia) are common manifestations as well [1] [4] [5] [6]. Rapid clinical deterioration, stemming from increased intracranial pressure, cerebral herniation, respiratory insufficiency requiring intubation, and status epilepticus, is encountered in a minority of cases [1] [4] [5] [6]. It must be noted that the majority of deaths by LACV occur due to La Crosse encephalitis, indicating that early recognition is vital for preventing complications [1] [4] [5]. In addition, long-term neurological sequelae are readily observed among survivors [5].

The signs and symptoms of La Crosse encephalitis point to a nonspecific infection of the CNS and the differential diagnosis is often turned toward more common causes of viral encephalitis, such as herpes simplex virus (HSV) and enteroviruses [1] [5]. However, the specific geographical location is of crucial importance for including LACV as a possible cause. Thus, a detailed patient history must cover recent traveling to endemic areas of the United States (or if patients are living in these areas) and note whether mosquito bites occurred. The physical examination, if conducted properly, can immediately point to a CNS infection, in which case both laboratory and microbiological studies should be employed. A lumbar puncture will show mild lymphocytic (or sometimes neutrophilic) pleocytosis, and increased protein levels are observed in up to 30% of patients, while leukocytosis in a complete blood count (CBC) is also seen [1] [2] [5]. A definite diagnosis of La Crosse encephalitis is made after conducting one of the two microbiological procedures - serology or polymerase chain reaction (PCR) [6] [7] [8]. Identification of immunoglobulin (Ig) M or high titer IgG antibodies is a reliable and effective method, whereas detection of viral deoxyribonucleic acid (DNA) in the cerebrospinal fluid (CSF) through molecular methods, such as PCR and reverse transcriptase-PCR has increased the overall efficacy in identifying LACV in human tissue [1] [5] [6] [7] [8].

There is no specific antiviral treatment for La Crosse Encephalitis. Management focuses on supportive care to relieve symptoms and prevent complications. This may include hospitalization for severe cases, where patients can receive intravenous fluids, medications to control fever and seizures, and respiratory support if needed. Early intervention and supportive care are crucial for improving outcomes.

The prognosis for La Crosse Encephalitis is generally favorable, especially in mild cases. Most patients recover fully without long-term effects. However, severe cases can lead to lasting neurological problems, such as cognitive deficits or seizure disorders. The risk of severe outcomes is higher in young children. Prompt medical attention and supportive care can improve the chances of a full recovery.

La Crosse Encephalitis is caused by the La Crosse virus, a member of the Bunyaviridae family. The virus is primarily transmitted to humans through the bite of infected Aedes mosquitoes, particularly the Aedes triseriatus species, also known as the eastern treehole mosquito. These mosquitoes are commonly found in wooded areas and are active during the day.

La Crosse Encephalitis is most commonly reported in the Midwestern and Appalachian regions of the United States. The disease primarily affects children under the age of 16, with most cases occurring during the late spring to early fall when mosquito activity is highest. While the disease is relatively rare, it is an important cause of viral encephalitis in endemic areas.

Once transmitted through a mosquito bite, the La Crosse virus enters the bloodstream and can cross the blood-brain barrier, leading to inflammation of the brain tissue. This inflammation, or encephalitis, is responsible for the neurological symptoms associated with the disease. The body's immune response to the virus can also contribute to the severity of the symptoms.

Preventing La Crosse Encephalitis involves reducing exposure to mosquito bites. This can be achieved by using insect repellent, wearing long sleeves and pants, and avoiding outdoor activities during peak mosquito activity times. Eliminating standing water around homes can also help reduce mosquito breeding sites. Community efforts to control mosquito populations are essential in endemic areas.

La Crosse Encephalitis is a mosquito-borne viral disease that primarily affects children and can lead to brain inflammation. While most cases are mild, severe cases can result in significant neurological complications. Diagnosis involves clinical evaluation and laboratory tests, and treatment focuses on supportive care. Prevention is key and involves reducing mosquito exposure.

For patients and families, understanding La Crosse Encephalitis is important for recognizing symptoms and seeking timely medical care. The disease is transmitted by mosquitoes, so taking preventive measures to avoid bites is crucial. If symptoms such as fever, headache, or confusion occur after mosquito exposure, it is important to consult a healthcare provider for evaluation and management.

1. McJunkin JE, de los Reyes EC, Irazuzta JE, et al. La Crosse encephalitis in children. N Engl J Med. 2001;344(11):801-807.
2. Davis LE, Beckham JD, Tyler KL. North American encephalitic arboviruses. Neurol Clin. 2008;26(3):727-ix.
3. Lambert AJ, Fryxell RT, Freyman K, et al. Comparative Sequence Analyses of La Crosse Virus Strain Isolated from Patient with Fatal Encephalitis, Tennessee, USA . Emerg Infect Dis. 2015;21(5):833-836.
4. Haddow AD, Odoi A. The Incidence Risk, Clustering, and Clinical Presentation of La Crosse Virus Infections in the Eastern United States, 2003–2007. Rénia L, ed. PLoS One. 2009;4(7):e6145.
5. Mandell GL, Bennett JE, Dolin R. Mandel, Douglas and Bennett's Principles and Practice of Infectious Diseases. 8th ed. Philadelphia, Pennsylvania: Churchill Livingstone; 2015.
6. Jones TF, Erwin PC, Craig AS, et al. Serological survey and active surveillance for La Crosse virus infections among children in Tennessee. Clin Infect Dis. 2000;31:1284-1287.
7. Lambert AJ, Nasci RS, Cropp BC, et al. Nucleic Acid Amplification Assays for Detection of La Crosse Virus RNA. J Clin Microbiol. 2005;43(4):1885-1889.
8. Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology. Seventh edition. Philadelphia: Elsevier/Saunders; 2013.